A Survey on the Under-treatment of hypercholeSterolemia (EPHESUS Trial)
EPHESUS
Evaluation of Perceptions, Knowledge and Compliance With tHE Guidelines for Secondary Prevention in Real Life Practice: A Survey on the Under-treatment of hypercholeSterolemia (EPHESUS Trial)
1 other identifier
observational
6,000
0 countries
N/A
Brief Summary
In this study, within the secondary prevention group patients ( diabetes mellitus, coronary artery disease, peripheral artery disease, who have had events atherosclerotic cerebrovascular ) , statin use requirement , patients compliance and reaching target LDL-cholesterol levels (according to European guidelines ) will be evaluated.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Nov 2015
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2015
CompletedFirst Submitted
Initial submission to the registry
November 17, 2015
CompletedFirst Posted
Study publicly available on registry
November 20, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2016
CompletedNovember 20, 2015
November 1, 2015
10 months
November 17, 2015
November 18, 2015
Conditions
Outcome Measures
Primary Outcomes (1)
The number of patients with secondary prevention group receiving appropriate lipid lowering therapy
2 months
Eligibility Criteria
Patients receiving lipid-lowering therapy within the secondary prevention group in Turkey
You may qualify if:
- Patients with coronary artery disease (acute coronary syndromes, post- myocardial infarction patients, who have a history of percutaneous coronary intervention , history of coronary artery by-pass graft )
- Patients with carotid artery lesions or peripheral artery disease ,
- Type 2 diabetes mellitus patients
You may not qualify if:
- acute coronary syndrome in last 1 month
- pregnancy or the first 6 months postpartum
- ICU patients or emergency patients...etc.(other than polyclinic)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (2)
Dogan V, Basaran O, Ozlek B, Celik O, Ozlek E, Cil C, Ozdemir IH, Rencuzogullari I, Ozpamuk Karadeniz F, Bekar L, Aktas M, Resulzade MM, Kalcik M, Aksan G, Cinier G, Halli Akay K, Mert KU, Biteker M, Kayikcioglu M. Evaluation of perceptions, knowledge and compliance with guidelines in real-life practice: A survey on the under-treatment of hypercholesterolemia. Turk Kardiyol Dern Ars. 2019 Oct;47(7):599-608. doi: 10.5543/tkda.2019.39293.
PMID: 31582673DERIVEDDogan V, Basaran O, Ozlek B, Celik O, Ozlek E, Mert KU, Rencuzogullari I, Mert GO, Dogan MM, Biteker M, Kayikcioglu M. Rationale, design, and methodology of the Evaluation of Perceptions, Knowledge, and Compliance with the Guidelines in Real Life Practice: A Survey on the Under-treatment of Hypercholesterolemia. Turk Kardiyol Dern Ars. 2018 Jan;46(1):47-53. doi: 10.5543/tkda.2017.73861.
PMID: 29339691DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assoc. Prof. Mugla Sitki Kocman University
Study Record Dates
First Submitted
November 17, 2015
First Posted
November 20, 2015
Study Start
November 1, 2015
Primary Completion
September 1, 2016
Study Completion
September 1, 2016
Last Updated
November 20, 2015
Record last verified: 2015-11